Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?

Author： Teschke Rolf Schulze Johannes Eickhoff Axel Danan Gaby

Publisher： MDPI

E-ISSN： 1422-0067|18|4|803-803

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.18, Iss.4, 2017-04, pp. : 803-803

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RUCAM in Drug and Herb Induced Liver Injury: The Update

By Danan Gaby Teschke Rolf

International Journal of Molecular Sciences, Vol. 17, Iss. 1, 2015-12 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite

Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States

By Hayashi Paul H.

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 201-201

MDPI

Access to resources Recommend Favorite

Molecular Research on Drug Induced Liver Injury

By Teschke Rolf Danan Gaby

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2018-01 ,pp. : 216-216

MDPI

Access to resources Recommend Favorite

Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury

By McEuen Kristin Borlak Jürgen Tong Weida Chen Minjun

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1335-1335

MDPI

Access to resources Recommend Favorite

Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury

By Ortega-Alonso Aida Stephens Camilla Lucena M. Isabel Andrade Raúl J.

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 714-714

MDPI

Access to resources Recommend Favorite